The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Garassino, Marina Chiara
One or more keywords matched the following items that are connected to Garassino, Marina Chiara
Item TypeName
Concept Adenosine
Concept Antigen-Antibody Complex
Concept Aged, 80 and over
Concept Aged
Concept Biology
Concept Ambulatory Care
Concept Carbazoles
Concept Catheterization
Concept Antineoplastic Combined Chemotherapy Protocols
Concept Carcinoma, Bronchogenic
Concept Antibodies, Monoclonal
Concept Autoimmune Diseases
Concept Cell Differentiation
Concept Bone Neoplasms
Concept Bronchial Neoplasms
Concept Azacitidine
Concept China
Concept Autoantibodies
Concept Biopsy
Concept Carcinoma, Non-Small-Cell Lung
Concept Carcinogens
Concept Cell Cycle
Concept Colonic Neoplasms
Concept Combined Modality Therapy
Concept gamma-Aminobutyric Acid
Concept Leucovorin
Concept C-Reactive Protein
Concept Cholesterol
Concept Hemoglobins
Concept Colonic Diseases
Concept Imidazoles
Concept Decision Support Techniques
Concept DNA Repair
Concept Cause of Death
Concept Immunoglobulin Fc Fragments
Concept Exons
Concept Erythropoietin
Concept Cost-Benefit Analysis
Concept Depression
Concept Cross-Sectional Studies
Concept Disease Susceptibility
Concept Myasthenia Gravis
Concept Fasting
Concept Metformin
Concept Mice, Transgenic
Concept Immunohistochemistry
Concept Mice, Nude
Concept Middle Aged
Concept Neutrophils
Concept Oxycodone
Concept Osteonecrosis
Concept Genetic Markers
Concept Glutamates
Concept Immunoglobulin G
Concept Guanine
Concept Cohort Studies
Concept Smoking
Concept Health Knowledge, Attitudes, Practice
Concept Stress, Psychological
Concept Humans
Concept United States
Concept Biomarkers, Tumor
Concept Biomarkers
Concept Carcinoma, Adenosquamous
Concept Antibodies, Blocking
Concept Multiple Sclerosis
Concept Case-Control Studies
Concept North America
Concept Apoptosis
Concept CD8-Positive T-Lymphocytes
Concept Cell Proliferation
Concept ras Proteins
Concept Angiogenesis Inhibitors
Concept Biomarkers, Pharmacological
Concept Antineoplastic Agents, Hormonal
Concept B7-H1 Antigen
Concept Proteomics
Concept NIH 3T3 Cells
Concept Tumor Burden
Concept Cell Growth Processes
Concept 5' Untranslated Regions
Concept 3' Untranslated Regions
Concept Information Dissemination
Concept Interdisciplinary Communication
Concept Caloric Restriction
Concept Mice
Concept Pyrazoles
Concept Quinazolines
Concept Biomedical Research
Concept Compassionate Use Trials
Concept Chemoradiotherapy
Concept Patient Preference
Concept Class I Phosphatidylinositol 3-Kinases
Concept Social Networking
Concept Antibodies, Monoclonal, Humanized
Concept Tetraspanin 28
Concept CTLA-4 Antigen
Concept Adaptor Proteins, Signal Transducing
Concept T-Lymphocytes, Cytotoxic
Concept Blotting, Western
Concept Colorectal Neoplasms
Concept Small Cell Lung Carcinoma
Concept NF-E2-Related Factor 2
Concept Multivariate Analysis
Concept Chemotherapy, Adjuvant
Concept 4-Butyrolactone
Concept Social Media
Concept Proto-Oncogene Proteins p21(ras)
Concept Receptor, ErbB-2
Concept Telemedicine
Concept Proto-Oncogene Proteins c-met
Concept Coronavirus
Concept Neoadjuvant Therapy
Concept Breast Neoplasms, Male
Concept Topotecan
Concept Cation Transport Proteins
Concept Extracellular Signal-Regulated MAP Kinases
Concept Administration, Metronomic
Concept Cell Cycle Checkpoints
Concept Programmed Cell Death 1 Receptor
Concept Cell Line, Tumor
Concept Quinazolinones
Concept Anti-Bacterial Agents
Concept Antineoplastic Agents, Phytogenic
Concept Brain Neoplasms
Concept Camptothecin
Concept Diagnosis, Differential
Concept DNA Helicases
Concept Follow-Up Studies
Concept Longitudinal Studies
Concept Lymphocytes
Concept Prospective Studies
Concept Retrospective Studies
Concept Signal Transduction
Concept Databases, Factual
Concept Mice, SCID
Concept Radiotherapy, Adjuvant
Concept Genes, erbB-1
Concept MicroRNAs
Concept Young Adult
Concept Patient Safety
Academic Article Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
Academic Article Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).
Academic Article Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
Academic Article Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.
Academic Article Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Academic Article Severity of COVID-19 in patients with lung cancer: evidence and challenges.
Academic Article The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
Academic Article Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
Academic Article Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience.
Academic Article Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Academic Article Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.
Academic Article ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.
Academic Article Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP).
Academic Article Regulation of PD-L1 Expression by NF-?B in Cancer.
Academic Article Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.
Academic Article Reversible palpebral ptosis following oxaliplatin infusion.
Academic Article Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes.
Academic Article Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy.
Academic Article Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Academic Article Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Academic Article Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity.
Academic Article Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT).
Academic Article Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Academic Article COVID-19 in patients with cancer: managing a pandemic within a pandemic.
Academic Article Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study.
Academic Article Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Academic Article Immunometabolic Status of COVID-19 Cancer Patients.
Academic Article Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Academic Article Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial).
Academic Article Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem.
Academic Article First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Academic Article Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Academic Article An oxaliplatin + 5-fluorouracil bolus + folinic acid (BFOL) regimen as first-line treatment in metastatic colorectal cancer patients.
Academic Article Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitors.
Academic Article Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial.
Academic Article Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer.
Academic Article Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey.
Academic Article Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.
Academic Article Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Academic Article At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer.
Academic Article Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.
Academic Article Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.
Academic Article Localized hand-foot syndrome after intra-arterial hepatic chemotherapy with floxuridine: a clinical case.
Academic Article The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate.
Academic Article Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
Academic Article Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.
Academic Article Perioperative or postoperative therapy for resectable gastric cancer?
Academic Article Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
Academic Article Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis.
Academic Article OncoAlert Round Table Discussions: The Global COVID-19 Experience.
Academic Article EGFR mutations and EGFR tyrosine kinase inhibitors.
Academic Article Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Academic Article Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
Academic Article Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study.
Academic Article Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
Academic Article Pembrolizumab plus Chemotherapy in Lung Cancer.
Academic Article Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non-small Cell Lung Cancer.
Academic Article Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.
Academic Article Response of thymoma to cetuximab.
Academic Article To Continue or Not to Continue? That Is the Question.
Academic Article Development and clinical indications of cetuximab.
Academic Article TERAVOLT: Thoracic Cancers International COVID-19 Collaboration.
Academic Article Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene.
Academic Article Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors.
Academic Article 2020s Heroes Are Not Fearless: The Impact of the COVID-19 Pandemic on Wellbeing and Emotions of Italian Health Care Workers During Italy Phase 1.
Academic Article Predicting response of molecular targeted therapies: a still possible challenge?
Academic Article Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment.
Academic Article SMO mutations confer poor prognosis in malignant pleural mesothelioma.
Academic Article Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
Academic Article High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases.
Academic Article RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients.
Academic Article Reply to FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS-mutated tumours in the randomised German AIO study KRK-0306.
Academic Article Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Academic Article Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.
Academic Article ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?
Academic Article BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience.
Academic Article Shifting From a "One Size Fits All" to a Tailored Approach for Immune-Related Adverse Events.
Academic Article Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
Academic Article Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Academic Article Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy.
Academic Article Bringing Onco-Innovation to Europe's Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine.
Academic Article Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy.
Academic Article Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Academic Article Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Academic Article The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.
Academic Article Cetuximab for colorectal cancer.
Academic Article To target or not to target, that is the question.
Academic Article [Locoregional therapy in hepatic metastases of colorectal cancer].
Academic Article Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer.
Academic Article Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology.
Academic Article Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms.
Academic Article Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Academic Article First Case Report of Pregnancy on Alectinib in a Woman With Metastatic ALK-Rearranged Lung Cancer: A Case Report.
Academic Article Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Academic Article Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program.
Academic Article Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases.
Academic Article Multiple sclerosis associated with pembrolizumab in a patient with non-small cell lung cancer.
Academic Article Impact of Patient Characteristics, Prior Therapy, and Sample Type on Tumor Cell Programmed Cell Death Ligand 1 Expression in Patients with Advanced NSCLC Screened for the ATLANTIC Study.
Academic Article Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR).
Academic Article Membrane Cholesterol Regulates Macrophage Plasticity in Cancer.
Academic Article Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways.
Academic Article Predictive models in palliative care.
Academic Article Do we really need another epidermal growth factor receptor tyrosine kinase inhibitor in first-line treatment for patients with non-small-cell lung cancer and EGFR mutations?
Academic Article Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients.
Academic Article The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
Academic Article Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancer.
Academic Article New findings on thymic epithelial tumors: Something is changing.
Academic Article Cognitive impairment and chemotherapy: a brief overview.
Academic Article G48A, a New KRAS Mutation Found in Lung Adenocarcinoma.
Academic Article Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
Academic Article Caring for Patients With Cancer During the COVID-19 Outbreak in Italy.
Academic Article Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting.
Academic Article Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis.
Academic Article Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study.
Academic Article Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review.
Academic Article COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Academic Article RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.
Academic Article Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 =50% who progress on first-line immunotherapy: real-world data from a European cohort.
Academic Article Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score =50% treated with front-line pembrolizumab.
Academic Article A lesson from vorinostat in pleural mesothelioma.
Academic Article Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab.
Academic Article CNS Efficacy of Osimertinib in Patients With T790M-Positive Advanced Non-Small-Cell Lung Cancer: Data From a Randomized Phase III Trial (AURA3).
Academic Article Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations.
Academic Article Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders.
Academic Article Afatinib for lung cancer: let there be light?
Academic Article Dissecting Pulmonary Large-Cell Carcinoma by Targeted Next Generation Sequencing of Several Cancer Genes Pushes Genotypic-Phenotypic Correlations to Emerge.
Academic Article Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
Academic Article Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
Academic Article Challenging Lung Carcinoma with Coexistent ?Np63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells.
Academic Article Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?
Academic Article Recurrent thrombosis followed by Lazarus response in ROS1 rearranged NSCLC treated with crizotinib: a case report.
Academic Article New strategies in colon cancer adjuvant therapy.
Academic Article LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
Academic Article Targeted therapy-induced diarrhea: A review of the literature.
Academic Article Bevacizumab for non-small-cell lung cancer.
Academic Article Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy number.
Academic Article Cetuximab for metastatic colorectal cancer.
Academic Article Can the response to a platinum-based therapy be predicted by the DNA repair status in non-small cell lung cancer?
Academic Article EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort.
Academic Article Diagnosis and management of typical and atypical lung carcinoids.
Academic Article New anti-emetic treatments.
Academic Article Accuracy of pathologic diagnosis for thymic epithelial tumors: a brief report from an Italian reference Center.
Academic Article Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.
Academic Article Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Academic Article Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.
Academic Article Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Academic Article Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancer.
Academic Article Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial.
Academic Article LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Academic Article Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189.
Academic Article Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Academic Article Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
Academic Article Real-world treatment outcomes with brigatinib in patients with pretreated ALK+ metastatic non-small cell lung cancer.
Academic Article Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches.
Academic Article Clinical management of patients with thymic epithelial tumors: the recommendations endorsed by the Italian Association of Medical Oncology (AIOM).
Academic Article Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey.
Academic Article Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407.
Academic Article Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations.
Academic Article On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma.
Academic Article COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response.
Academic Article Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.
Academic Article Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Academic Article Comprehensive metastatic ablation in advanced NSCLC through biology-guided radiotherapy - A path forward?
Academic Article Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Academic Article Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer.
Academic Article Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studies.
Academic Article Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Academic Article Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Academic Article A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry.
Academic Article Adenosine Pathway in NSCLC With Molecular Drivers: Can Oncogene Addiction Translate Into Immune Addiction?
Academic Article Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN.
Academic Article SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.
Academic Article Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis.
Academic Article Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
Academic Article Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies.
Academic Article Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
Academic Article Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Academic Article Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide.
Academic Article Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors.
Academic Article Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
Academic Article Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology.
Academic Article PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.
Academic Article Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.
Academic Article Postoperative Complications of Thymectomy in Myasthenia Gravis: Does Steroid Use Play a Role?
Academic Article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study.
Academic Article To the Editor.
Academic Article Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial.
Academic Article Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Academic Article Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC.
Academic Article Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study.
Academic Article Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee survey.
Concept Pemetrexed
Concept Darbepoetin alfa
Concept Bevacizumab
Concept Immunosenescence
Concept Cetuximab
Concept Pregabalin
Concept Erlotinib Hydrochloride
Concept Kelch-Like ECH-Associated Protein 1
Concept Circulating MicroRNA
Concept Betacoronavirus
Concept Liquid Biopsy
Concept Injection Site Reaction
Concept Circulating Tumor DNA
Concept Triple Negative Breast Neoplasms
Academic Article Response to Letter to the Editor From Binghao Zhao et al.
Academic Article Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4).
Academic Article Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Academic Article STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
Academic Article Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
Academic Article Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.
Academic Article Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.
Academic Article PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
Academic Article What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
Academic Article First-line cemiplimab monotherapy and continued cemiplimab beyond progression plus chemotherapy for advanced non-small-cell lung cancer with PD-L1 50% or more (EMPOWER-Lung 1): 35-month follow-up from a mutlicentre, open-label, randomised, phase 3 trial.
Academic Article Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations.
Academic Article Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Academic Article Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden.
Academic Article High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Academic Article Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B.
Academic Article Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Academic Article Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies.
Academic Article Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).
Academic Article Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
Academic Article Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT).
Academic Article Response to Letter to the Editor From Shaorong Yu and Jifeng Feng.
Academic Article Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Academic Article Mesothelioma: Pleural, Version 1.2024.
Search Criteria
  • Genes erbB
  • 1